THE TRANSLATIONAL GENOMICS RESEARCH INSTITUTE

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 4580
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 29226
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 14192
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 11156
 
  
 
C07D HETEROCYCLIC COMPOUNDS 5157
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 594
 
  
 
C07K PEPTIDES 5131
 
  
 
G06F ELECTRIC DIGITAL DATA PROCESSING 5442
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 495
 
  
 
C40B COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES 418

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0206,311 METHOD OF CHARACTERIZING SEQUENCES FROM GENETIC MATERIAL SAMPLESApr 03, 17Jul 20, 17[G06F]
2017/0107,578 COMPOSITIONS, METHODS AND KITS FOR CHARACTERIZING AND SCREENING FOR SMALL CELL OVARIAN CARCINOMAMar 23, 15Apr 20, 17[A61K, C12Q, C12N]
2016/0137,607 Autophagy InhibitorsNov 19, 15May 19, 16[C07D]
2016/0038,498 METHODS FOR THE TREATMENT OF CANCEROct 23, 15Feb 11, 16[A61K]
2016/0039,931 Hybridoma Clones and Monoclonal Antibodies to Tetraspanin 8Mar 17, 14Feb 11, 16[G01N, C07K]
2016/0032,002 Hybridoma Clones and Monoclonal Antibodies to CD9Mar 17, 14Feb 04, 16[C07K]
2016/0001,198 Mobile Phase Degassing for Nano-Flow Liquid ChromatographyFeb 25, 14Jan 07, 16[G01N, B01D]
2015/0232,896 ISOLATED GENES AND TRANSGENIC ORGANISMS FOR PRODUCING BIOFUELSSep 18, 13Aug 20, 15[C12P]
2015/0167,056 PRIMERS, ASSAYS AND METHODS FOR DETECTING BURKHOLDERIA PSEUDOMALLEI AND BURKHOLDERIA MALLEIMay 15, 13Jun 18, 15[C12Q]
2014/0195,165 SYSTEMS AND METHODS FOR IDENTIFYING THE RELATIONSHIPS BETWEEN A PLURALITY OF GENESNov 13, 13Jul 10, 14[G06F]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9914978 Methods, kits, and compositions useful in selecting an antibiotic to treat MRSAMar 18, 11Mar 13, 18[C07H, C12Q, C12M]
9872857 Methods of using propentofylline to treat glioma and glioblastomaMar 14, 16Jan 23, 18[A61K, C12Q, G01N]
9862773 Hybridoma clones and monoclonal antibodies to CD9Mar 17, 14Jan 09, 18[C12N, G01N, C07K]
9850303 Hybridoma clones and monoclonal antibodies to tetraspanin 8Mar 17, 14Dec 26, 17[C12N, G01N, C07K]
9834823 subtypeJul 02, 13Dec 05, 17[C12Q, C12P]
9797882 Method of screening for a compound for inhibitory activity of FN14-tweak interactionJul 09, 14Oct 24, 17[A61K, G01N]
9750741 Targeted therapies for cancerMar 17, 14Sep 05, 17[A61K, A01N, C12Q]
9745634 Systems and methods for diagnosing and treating cancerNov 20, 14Aug 29, 17[C12Q, C12P]
9738717 Hybridoma clones, monoclonal antibodies, and methods of useMay 15, 13Aug 22, 17[A61K, G01N, C07K]
9663826 System and method of genomic profilingFeb 15, 13May 30, 17[C12Q]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0000,784 Autophagy InhibitorsAbandonedDec 05, 14Jan 05, 17[A61K]
2016/0340,742 Method of Identifying Tyrosine Kinase Receptor Rearrangements in PatientsAbandonedFeb 04, 15Nov 24, 16[C12Q]
2016/0130,654 SYSTEMS AND METHODS FOR DIAGNOSING AND TREATING CANCERAbandonedDec 05, 14May 12, 16[A61K, C12Q, C12N, G01N]
2016/0058,777 IDENTIFICATION AND TREATMENT OF CANCER SUBSETSAbandonedNov 02, 15Mar 03, 16[A61K]
2015/0329,916 METHODS AND KITS USED IN CLASSIFYING ADRENOCORTICAL CARCINOMAAbandonedJul 23, 15Nov 19, 15[C12Q, G01N]
2015/0216,848 COMPOUNDS THAT INHIBIT TAU PHOSPHORYLATIONAbandonedMar 11, 15Aug 06, 15[A61K]
2015/0081,676 BIOLOGICAL DATA STRUCTURE HAVING MULTI-LATERAL, MULTI-SCALAR, AND MULTI-DIMENSIONAL RELATIONSHIPS BETWEEN MOLECULAR FEATURES AND OTHER DATAAbandonedNov 24, 14Mar 19, 15[G06F]
2014/0322,243 METHODS OF DETECTING BREAST CANCER BRAIN METASTASIS WITH GENOMIC AND EPIGENOMIC BIOMARKERSAbandonedApr 26, 14Oct 30, 14[C12Q]
2014/0303,025 METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF NEURODEGENERATIVE DISEASESAbandonedJun 18, 14Oct 09, 14[C12Q]
2014/0272,993 METHOD OF SEQUENCING A FULL MICRORNA PROFILE FROM CEREBROSPINAL FLUIDAbandonedMar 15, 14Sep 18, 14[C12Q]
2014/0274,741 METHODS TO CAPTURE AND SEQUENCE LARGE FRAGMENTS OF DNA AND DIAGNOSTIC METHODS FOR NEUROMUSCULAR DISEASEAbandonedMar 17, 14Sep 18, 14[C12Q]
2014/0057,261 METHODS OF DIAGNOSING, CLASSIFYING AND TREATING ENDOMETRIAL CANCER AND PRECANCERAbandonedAug 22, 13Feb 27, 14[G01N]
2014/0024,539 BIOMARKERS AND METHODS OF USE THEREOFAbandonedFeb 02, 12Jan 23, 14[C12Q]
2013/0323,733 METHODS OF ASSESSING A RISK OF DEVELOPING NECROTIZING MENINGOENCEPHALITISAbandonedMay 29, 13Dec 05, 13[C12Q]
2013/0237,444 GBM MOLECULAR CONTEXTS ASSOCIATED WITH PATIENT SURVIVALAbandonedMar 12, 13Sep 12, 13[C12Q]
2013/0209,460 METHODS AND KITS USED IN IDENTIFYING GLIOBLASTOMAAbandonedMar 18, 13Aug 15, 13[C12Q]
2013/0165,474 COMPOUNDS THAT INHIBIT TAU PHOSPHORYLATIONAbandonedAug 17, 11Jun 27, 13[A61K]
2013/0157,873 METHODS OF ASSESSING A RISK OF DEVELOPING NECROTIZING MENINGOENCEPHALITISAbandonedMay 19, 11Jun 20, 13[C12Q]
2013/0116,196 MUSCLE FATIGUE SUBSTANCE CYTOKINES AND METHODS OF INHIBITING TUMOR GROWTH THEREWITHAbandonedNov 05, 12May 09, 13[A61K, C12N, A61P]
2013/0109,589 SINGLE NUCLEOTIDE POLYMORPHISMS ASSOCIATED WITH AMYOTROPHIC LATERAL SCLEROSISAbandonedDec 17, 12May 02, 13[C12Q]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.